about
Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cellsAntiplatelet agentsTen novel Diamond-Blackfan anemia mutations and three polymorphisms within the rps19 geneMethionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolismGenetic alterations underlying the pathogenesis of MALT lymphomaMurine recessive hereditary spherocytosis, sph/sph, is caused by a mutation in the erythroid alpha-spectrin geneManagement of the myeloproliferative disorders : distinguishing data from dogma.Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemia.Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?Gene expression in CD34(+) cells from normal bone marrow and leukemic origins.Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.Do anthracyclines have a role in the therapy of multiple myeloma?Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits.Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura.Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders.The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma.Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment.Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia.Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.Mortality in severe, non aggressively treated adult autoimmune thrombocytopenia.HPA-genotyping and antiplatelet antibodies in female blood donors.A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.Balance between acute graft-versus-host disease and graft-versus-tumor effect after reduced-intensity transplantation for metastatic renal cell carcinoma.Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management.Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disorders.Immune-mediated thrombocytopenic purpura associated with Toxoplasma gondii infection in an immunocompetent patient.Tcf/Lef transcription factors during T-cell development: unique and overlapping functions.HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies.Use of fludarabine in the treatment of acute myeloid leukemia.Erythropoietin and erythropoiesis: polycythemias due to disruption of oxygen homeostasis.Choice of replacement therapy for hemophilia: recombinant products only?Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?The 5TMM series: a useful in vivo mouse model of human multiple myeloma.Reactive plasmacytoses, a model for studying the biology of human plasma cell progenitors and precursors.Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
P1433
Q24292769-ED5D504A-87AD-4424-A877-D110BF6678A3Q28168916-782161C4-C961-41E4-AA85-B540CBAE694AQ28204514-021B4398-70EC-4E51-9E97-C34C63EC9A66Q28211016-31CAB03E-BD26-4CE9-BF8A-702BA17518B9Q28215110-A05382D4-E893-47A3-9E4F-64675F83E957Q28590043-37440C32-CD63-42DE-8120-CDBABC219AF3Q30937966-687D1DC7-238E-4D1A-9FDF-6FC2C760EB11Q31045831-09C272E6-ADBE-42E8-B4EF-5394DCBD981BQ31045857-C3DECF60-866A-4C0E-9BE8-60C44B255F87Q32068606-C41D410A-80DC-4EDB-A2BF-FC4A4B6CD66CQ33182153-B916E926-D419-44F1-95B9-D38FF8FDF816Q33183536-C3008A7C-5FBF-4B1C-A5BE-8C5C02047096Q33341744-A8819530-12BC-48C5-91CA-013E6ED87C3AQ33341747-ECAF5ECC-9E10-4554-A073-193DF7DD7092Q33341750-74901A1F-6704-4B56-829B-51035A31C252Q33341753-4F50861C-5E5E-4E0E-A3A4-B8ADB6594761Q33341756-CA3E2F05-0A23-4FCC-8BE3-0B4927282E04Q33342015-81E08540-B4A1-4E93-9E43-334CD5E0AEFFQ33342020-A8AAA397-B3DA-488B-9C77-8EA3A31BD702Q33343171-564E9CE6-480E-4FE1-95A9-AAEB68EDB72FQ33344823-4B0F9875-9D78-4487-B077-7BACBB8BEA93Q33356859-4BA824E6-7DD2-447D-A129-CF19CA0278CDQ33356862-BABA4695-0B0B-4809-B8B8-1EDE7868EFBEQ33356865-7C7AB8D8-6CCE-4A70-AD68-C6167A136AEFQ33358136-FC2CD4E6-7526-4A96-AB4D-33D48ACE71ABQ33361012-3D409A48-0661-4702-BE8E-4B991C3591DEQ33361015-3F0C4364-5F1C-4542-BC7B-F4493519F2A9Q33361201-0E684A70-25C7-42D8-A244-0D48C6245ED7Q33363002-152D3C08-61D8-4B49-8740-0FBC437770D2Q33363906-29FEC6A5-4359-489C-AC3F-865CD93ACBEDQ34120961-4EA7A488-E98C-4628-B86A-A8509E105809Q34120965-926A003F-2EF7-45C1-9C18-56F2A0A3F9F4Q34264126-82AD4D80-97C3-4D85-8452-B9C8CC482EA6Q34312791-9159C954-8CDE-49A3-B5AF-54EC648A1AE6Q34326242-DA22BC08-9FB0-4AE2-9E2C-890A4FC5E4DAQ34580341-5FFC0DC3-2D12-4999-A63D-E00CBF13F882Q34580347-67D65935-D8D7-4FA2-90D0-04C7B6B1EBD4Q34580353-3822C7C9-EC36-41BC-8850-8C9C3DEC9FE4Q34580357-6C28763F-9455-4D8D-A434-B1051B74A656Q34580363-93ADDF3C-245B-4153-8BC8-169D56A7CA79
P1433
description
journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
wetenschappelijk tijdschrift van Nature Publishing Group
@nl
wissenschaftliche Fachzeitschrift
@de
name
The Hematology Journal
@ast
The Hematology Journal
@da
The Hematology Journal
@de
The Hematology Journal
@en
The Hematology Journal
@es
The Hematology Journal
@fo
The Hematology Journal
@fr
The Hematology Journal
@is
The Hematology Journal
@it
The Hematology Journal
@kl
type
label
The Hematology Journal
@ast
The Hematology Journal
@da
The Hematology Journal
@de
The Hematology Journal
@en
The Hematology Journal
@es
The Hematology Journal
@fo
The Hematology Journal
@fr
The Hematology Journal
@is
The Hematology Journal
@it
The Hematology Journal
@kl
altLabel
Hematology Journal
@da
Hematology Journal
@de
Hematology Journal
@en
prefLabel
The Hematology Journal
@ast
The Hematology Journal
@da
The Hematology Journal
@de
The Hematology Journal
@en
The Hematology Journal
@es
The Hematology Journal
@fo
The Hematology Journal
@fr
The Hematology Journal
@is
The Hematology Journal
@it
The Hematology Journal
@kl
P3181
P4616
P1055
P1156
P1277
P1476
The Hematology Journal
@en
P1813
Hematol J
@en